News & Media

The SBS 5.0 Sheathed Bipolar Sealer gives spine surgeons the ability to optimize speed and continuity in surgical cases

Medtronic reported results that show the effectiveness of the Aquamantys System in limiting blood loss and reducing transfusions during spinal surgery

Medtronic, Inc. (NYSE: MDT) announced today the launch of the Aquamantys Mini EVS 3.4 Epidural Vein Sealer.

Medtronic, Inc. announced today that it has received 510(k) clearance from the FDA for its Aquamantys®3 System as well as the new 8.2L Bipolar Sealer with Cutting.

Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of two privately held companies, PEAK Surgical, Inc. and Salient Surgical Technologies, Inc.

The application deadline has been extended to September 1, 2011 by 5:00 p.m, Eastern Time.

Medtronic announced today that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc.

Salient Surgical Technologies, Inc., has received 510(k) clearance from the FDA for the AQUAMANTYS bipolar sealer for use in blunt dissection.

Salient Surgical Technologies, Inc., has launched an expanded global medical education program.

For Salient Surgical Technologies, a custom iPad app is just what the doctor ordered - or, rather, just the trick to get the doctor to place an order.